Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Foresite Capital

Venture Capital · Founded 2011 · San Francisco, United States

121 portfolio companies Venture Capital · $18B invested · 181 investments · Investor rank #145 · Last investment 6/2026
Portfolio companies ↑ 36% 5y
121
Decacorns
2
Thoroughbreds ↑ 9% 5y
25
Exits

Foresite Capital’s biggest exits.

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from Foresite Capital’s transaction record.

$1.8B IPO · 2015
Entered Series B+Now $38BHealth
$385M IPO · 2013
Entered Series B+Now $12BHealth
$90M IPO · 2016
Entered Series B+Now $8.5BHealth
$250M IPO · 2020
Entered Series B+Now $6.5BHealth
$372M IPO · 2018
Entered Series B+Now $5.8BHealth
$1.2B IPO · 2024
Entered Series B+Now $5.3BHealth
$3.7B IPO · 2019
Entered Series B+Now $5.1BHealth
$2.4B IPO · 2026
Entered Series B+Now $4.2BHealth
$587M IPO · 2019
Entered Series B+Now $4.1BHealth
$2.4B IPO · 2019
Entered Series B+Now $3.5BHealth
IPO · 2024
Entered Series ANow $3.2BHealth
$2.8B acquisition · 2020
Entered Series B+Health
Portfolio analysis

Where Foresite Capital's portfolio is concentrated.

Distribution of portfolio companies by headquarters country, sector, entry stage and current growth stage. Across all 121 portfolio companies. "Stage entered" is the first priced round the investor joined, derived from the investor’s transaction history.

By countryCount
  1. USA110
  2. UK6
  3. Ireland2
  4. China1
  5. Hong Kong1
  6. Netherlands1
By sectorCount
  1. Health120
  2. Enterprise Software3
  3. Chemicals1
  4. Education1
  5. Food1
  6. Home Living1
  7. Semiconductors1
  8. Wellness Beauty1
By stage enteredCount
  1. Series B+87
  2. Series A25
  3. Seed2
By growth stageCount
  1. Late Growth95
  2. Breakout Stage25
  3. Early Growth1
Portfolio market map

Inside Foresite Capital's portfolio.

The 60 highest-funded portfolio companies, of 121 tracked.

Eikon Therapeutics
Health
$272M
Xaira Therapeutics
Health · Unicorn
$2.7B
Kriya Therapeutics
Health · Unicorn
$1.3B
Cue
Health
Element Biosciences
Health · Unicorn
$1.4B
SomaLogic
Health
Parabilis Medicines
Health · Unicorn
$4.2B
Odyssey Therapeutics
Health
$696M
Obsidian Therapeutics
Health
$642M
Avenzo Therapeutics
Health
$240M
Maze Therapeutics
Health
$140M
Insitro
Health · Unicorn
$1.6B
Alumis
Health · Unicorn
$3.2B
Solid Biosciences
Health
$498M
DNAnexus
Health
$600M
Olema Oncology
Health
$500M
Invivyd
Health · Unicorn
$1.8B
Inscripta
Health
$600M
Quantum-Si
Health
$56M
Abcuro
Health
$800M
Adaptive Biotechnologies
Health · Unicorn
$3.5B
Cullinan Therapeutics
Health
$738M
Candid Therapeutics
Health · Unicorn
$2.0B
Mammoth Biosciences
Health · Unicorn
$1.0B
Affinivax
Health · Unicorn
$2.1B
Tango Therapeutics
Health · Unicorn
$4.3B
Denali Therapeutics
Health · Unicorn
$1.5B
Juvenescence
Health
$550M
Delfi Diagnostics
Health
$900M
Seaport Therapeutics
Health
$939M
Ikena Oncology
Health
$629M
CG Oncology
Health · Unicorn
$5.3B
Genapsys
Health
Orchard Therapeutics
Health
$303M
ORIC Pharmaceuticals
Health
$832M
Latigo Biotherapeutics
Health
$600M
Crossover Health Management Services
Health
$672M
Vaxcyte
Health · Unicorn
$6.5B
LifeMine Therapeutics
Health
$700M
Midi Health
Health · Unicorn
$1.0B
Generation Bio
Health
Everly Health
Health · Unicorn
$2.9B
Twist Bioscience
Health · Unicorn
$5.8B
Peloton Therapeutics
Health · Unicorn
$1.0B
RAPT Therapeutics
Health · Unicorn
$1.5B
Thyme Care
Health · Unicorn
$1.0B
Arcus Biosciences
Health · Unicorn
$2.7B
bit.bio
Health
$200M
Cerevance
Health
$255M
10X Genomics
Health · Unicorn
$5.1B
Third Arc Bio
Health
$825M
Remix Therapeutics
Health
$280M
Kura Oncology
Health
$408M
Aetion
Health
$440M
VelosBio
Health · Unicorn
$2.8B
Kinnate Biopharma
Health
Alector
Health
Decibel Therapeutics
Health
$58M
ALX Oncology
Health
$152M
Korsana Biosciences
Health
$600M
Portfolio founders

Where Foresite Capital's portfolio founders come from.

160 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States137
  2. United Kingdom4
  3. China2
  4. Germany2
  5. Isle of Man2
  6. Switzerland2
  7. Australia1
  8. Canada1
  9. France1
  10. India1
UniversityCount
  1. Stanford University17
  2. Harvard University16
  3. Massachusetts Institute of Technology8
  4. University of California, Berkeley8
  5. University of Pennsylvania6
  6. Harvard Business School5
  7. Stanford University School of Medicine5
  8. Johns Hopkins University4
  9. University of Cambridge4
  10. University of Wisconsin-Madison4
Previous companyCount
  1. Stanford University8
  2. Dana-Farber Cancer Institute4
  3. Genentech4
  4. Alantos Pharmaceuticals3
  5. Brigham and Women's Hospital3
  6. Illumina3
  7. Lehman Brothers3
  8. Massachusetts General Hospital3
  9. Pfizer3
  10. University of California, Berkeley3
Every figure on this page is sourced live from the Dealroom next-gen API. Sections v1 shows that the API does not yet expose — shareholding-based holdings, Power-Law rankings & vintage time-series, entity-filtered news, and market sentiment — are omitted here rather than sourced elsewhere.